Treatment and Prevention Strategies

  • Your Selections:

Refine Results



6 More Ebola Cases Reported In DRC; World Vision Reports Examine Outbreak’s Impact On Children; NPR Profiles Congolese Doctor Heading Response

CIDRAP News: Ebola total climbs by 6 more cases “Six more Ebola infections have been confirmed in the Democratic Republic of Congo (DRC) outbreaks, part of fluctuating levels that health officials have warned about in the wake of recent attacks and security incidents that have temporarily shut down response activities…

Trump Administration’s Expanded Mexico City Policy Hinders HIV/AIDS Response Among Women, Girls, Planned Parenthood Officials Say

Planned Parenthood Global/Medium: A Catch-22 for Women and Girls: How the Global Gag Rule Attacks the HIV/AIDS Response In this post, ChloĆ« Cooney, senior director of strategy and programs for Planned Parenthood Global, and Caitlin Horrigan, director of global advocacy for Planned Parenthood Federation of America, discuss the impact of…

USAID Post Discusses How DREAMS Initiative Helping Young Women In Uganda

USAID/Medium: I’m Empowered and Resilient! I’m Living the Dream! In this post, Betty Kagoro, communications specialist at USAID’s Mission in Uganda, discusses PEPFAR’s DREAMS Initiative and profiles several women who are involved in the program in Tedum, Uganda. Kagoro writes, “USAID, through the DREAMS Initiative, is working with partners to…

DRC Officials Report 4 More Ebola Cases As Outbreak Continues Amid Security Concerns

CIDRAP News: Four more Ebola cases reported as outbreak marches on “The World Health Organization’s (WHO’s) Ebola dashboard reflects 4 new cases today, raising the outbreak total to 3,324, including 2,206 deaths, a sign that the violence of November has indeed extended the outbreak in the Democratic Republic of the…

Nations Must Address Regulatory, Other Barriers To PrEP Access, UNAIDS Says

UNAIDS: Barriers to PrEP must be removed This update discusses the benefits of oral pre-exposure prophylaxis (PrEP) and says “further global expansion of PrEP requires countries to address regulatory issues and other barriers that are stopping people who want to use PrEP from doing so” (12/9).

HIV Prevention Group Files Petition With U.S. Patents Office Alleging Gilead Delayed Improved HIV Drug Development To Gain Profits From Older Medicines

Washington Post: Gilead delayed safer HIV drug to extend monopoly profits, advocates allege “…An HIV-prevention group called PrEP4All Collaboration filed a petition Wednesday with the U.S. Patent and Trademark Office contending Gilead knew its new, improved drug — approved in 2015 and now part of Gilead’s combination therapies Genvoya and…